AIC
UTHR icon

Ameritas Investment Company’s United Therapeutics UTHR Stock Holding History

Ameritas Investment Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,494
Closed -$250K – 2020
2021
Q1 		$250K Buy
+1,494
New +$249K 0.02% 513
2020
Q2 		– Sell
-13
Closed -$1K – 1535
2020
Q1 		$1K Buy
+13
New +$1.24K ﹤0.01% 1708
2019
Q2 		– Sell
-13
Closed -$2K – 846
2019
Q1 		$2K Sell
13
-37
-74% -$4.31K ﹤0.01% 866
2018
Q4 		$5K Buy
+50
New +$5.8K ﹤0.01% 1229

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ameritas Investment Company's UTHR Position: Q2 2021 in Review

Ameritas Investment Company sold out of United Therapeutics (UTHR) in Q2 2021, closing a stake of 1,494 shares — an estimated $250K sold.

Ameritas Investment Company first reported a position in UTHR in Q4 2018 and held it in 4 quarters. The position peaked at $250K in Q1 2021. 403 funds tracked by Wall St. Rank hold UTHR as of Q2 2021.

  • Ameritas Investment Company reported no remaining United Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 1,494 United Therapeutics shares in Q2 2021, an estimated $250K.
  • Ameritas Investment Company first reported a position in United Therapeutics in Q4 2018 and held it in 4 quarters.
  • Ameritas Investment Company's United Therapeutics position peaked at $250K in Q1 2021.
  • 403 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.